BR9916893A - Tratamento - Google Patents

Tratamento

Info

Publication number: BR9916893A
Authority: BR; Brazil
Prior art keywords: hepatitis; treatment; virus; vaccine; antiviral agent
Prior art date: 1999-01-12

Application number

BR9916893-6A

Other languages

English (en)

Portuguese (pt)

Inventor

Gillian Frances Atkinson

Ronald James Boon

Pierre G Vandepapeliere

Martine Anne Cecil Wettendorff

Original Assignee

Smithkline Beecham Biolog

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-01-12

Filing date

1999-12-21

Publication date

2001-11-20

1999-12-21 Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog

2001-11-20 Publication of BR9916893A publication Critical patent/BR9916893A/pt

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Virology (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Molecular Biology (AREA)
Communicable Diseases (AREA)
Immunology (AREA)
Microbiology (AREA)
Mycology (AREA)
Endocrinology (AREA)
Biotechnology (AREA)
Oncology (AREA)
Gastroenterology & Hepatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

BR9916893-6A 1999-01-12 1999-12-21 Tratamento BR9916893A (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB9900630		1999-01-12
PCT/EP1999/010295 WO2000041463A2 (fr)	1999-01-12	1999-12-21	Nouveau traitement

Publications (1)

Publication Number	Publication Date
BR9916893A true BR9916893A (pt)	2001-11-20

Family

ID=10845878

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR9916893-6A BR9916893A (pt)	1999-01-12	1999-12-21	Tratamento

Country Status (19)

Country	Link
EP (1)	EP1140163A2 (fr)
JP (1)	JP2002534438A (fr)
KR (1)	KR20010090011A (fr)
CN (1)	CN1391482A (fr)
AR (1)	AR022250A1 (fr)
AU (1)	AU760574B2 (fr)
BR (1)	BR9916893A (fr)
CA (1)	CA2359110A1 (fr)
CO (1)	CO5241355A1 (fr)
CZ (1)	CZ20012544A3 (fr)
HK (1)	HK1041434A1 (fr)
HU (1)	HUP0105070A2 (fr)
IL (1)	IL144186A0 (fr)
NO (1)	NO20013337L (fr)
NZ (1)	NZ512890A (fr)
PL (1)	PL349347A1 (fr)
TR (1)	TR200102024T2 (fr)
WO (1)	WO2000041463A2 (fr)
ZA (1)	ZA200105690B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1999061056A2 (fr)	1998-05-22	1999-12-02	Loeb Health Research Institute At The Ottawa Hospital	Methodes et produits permettant d'induire une immunite au niveau des muqueuses
CN1560078B (zh)	1998-07-31	2011-06-22	株式会社国际癌症免疫研究所	基于癌抑制基因wt1的产物的癌抗原
CA2440303C (fr)	2001-03-22	2013-03-19	Haruo Sugiyama	Peptide modifie wt1
US8735357B2 (en)	2001-09-28	2014-05-27	International Institute Of Cancer Immunology, Inc.	Method of inducing antigen-specific T cells
JPWO2003028758A1 (ja) *	2001-09-28	2005-01-13	治夫杉山	抗原特異的ｔ細胞の誘導方法
MY131488A (en) *	2002-04-08	2007-08-30	Bristol Myers Squibb Co	Low dose liquid entecavir formulations and use
PT2241325E (pt)	2002-10-29	2012-04-12	Coley Pharm Gmbh	Utilização de oligonucleótidos cpg no tratamento de infecção com vírus da hepatite c
AU2003300919A1 (en)	2002-12-11	2004-06-30	Coley Pharmaceutical Gmbh	5' cpg nucleic acids and methods of use
CN100443117C (zh) *	2003-05-13	2008-12-17	深圳康泰生物制品股份有限公司	一种治疗性乙型肝炎的疫苗制剂、其制备方法及其用途
US8541167B2 (en)	2004-06-03	2013-09-24	Saint Louis University	Methods and compositions for vaccination
AR065504A1 (es) *	2007-02-28	2009-06-10	Ct Ingenieria Genetica Biotech	Terapia combinada para el tratamiento de la hepatitis b cronica. uso.
WO2020134682A1 (fr) *	2018-12-24	2020-07-02	南京远大赛威信生物医药有限公司	Préparation pharmaceutique pour le traitement de l'hépatite b, procédé de préparation s'y rapportant et utilisation associée
EP4321173A1 (fr) *	2021-04-07	2024-02-14	Denka Company Limited	Activateur d'activité d'adjuvant et composition d'adjuvant

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2109921T3 (es) *	1989-07-25	1998-02-01	Smithkline Beecham Biolog	Nuevos antigenos y procedimientos para su preparacion.
EP1064025B1 (fr) *	1998-03-09	2006-09-13	GlaxoSmithKline Biologicals S.A.	Compositions de vaccins combines

1999
- 1999-12-21 PL PL99349347A patent/PL349347A1/xx not_active Application Discontinuation
- 1999-12-21 KR KR1020017008833A patent/KR20010090011A/ko not_active Application Discontinuation
- 1999-12-21 CN CN99816471A patent/CN1391482A/zh active Pending
- 1999-12-21 CZ CZ20012544A patent/CZ20012544A3/cs unknown
- 1999-12-21 AU AU21009/00A patent/AU760574B2/en not_active Ceased
- 1999-12-21 TR TR2001/02024T patent/TR200102024T2/xx unknown
- 1999-12-21 EP EP99965531A patent/EP1140163A2/fr not_active Withdrawn
- 1999-12-21 HU HU0105070A patent/HUP0105070A2/hu unknown
- 1999-12-21 IL IL14418699A patent/IL144186A0/xx unknown
- 1999-12-21 JP JP2000593088A patent/JP2002534438A/ja active Pending
- 1999-12-21 WO PCT/EP1999/010295 patent/WO2000041463A2/fr not_active Application Discontinuation
- 1999-12-21 CA CA002359110A patent/CA2359110A1/fr not_active Abandoned
- 1999-12-21 BR BR9916893-6A patent/BR9916893A/pt not_active IP Right Cessation
- 1999-12-21 NZ NZ512890A patent/NZ512890A/en unknown
2000
- 2000-01-11 AR ARP000100107A patent/AR022250A1/es not_active Application Discontinuation
- 2000-01-12 CO CO00001261A patent/CO5241355A1/es not_active Application Discontinuation
2001
- 2001-07-05 NO NO20013337A patent/NO20013337L/no not_active Application Discontinuation
- 2001-07-11 ZA ZA200105690A patent/ZA200105690B/xx unknown
2002
- 2002-02-19 HK HK02101211.9A patent/HK1041434A1/zh unknown

Also Published As

Publication number	Publication date
KR20010090011A (ko)	2001-10-17
TR200102024T2 (tr)	2001-12-21
EP1140163A2 (fr)	2001-10-10
CZ20012544A3 (cs)	2002-01-16
AR022250A1 (es)	2002-09-04
JP2002534438A (ja)	2002-10-15
HK1041434A1 (zh)	2002-07-12
NO20013337L (no)	2001-08-17
WO2000041463A3 (fr)	2000-11-09
PL349347A1 (en)	2002-07-15
IL144186A0 (en)	2002-05-23
ZA200105690B (en)	2002-09-25
NO20013337D0 (no)	2001-07-05
WO2000041463A2 (fr)	2000-07-20
AU2100900A (en)	2000-08-01
CA2359110A1 (fr)	2000-07-20
CO5241355A1 (es)	2003-01-31
NZ512890A (en)	2003-09-26
HUP0105070A2 (hu)	2002-04-29
AU760574B2 (en)	2003-05-15
CN1391482A (zh)	2003-01-15

Similar Documents

Publication	Publication Date	Title
TWI317735B (en)	2009-12-01	Methods and compositions for treating hepatitis c virus
BR9916893A (pt)	2001-11-20	Tratamento
BR0011433B1 (pt)	2013-10-22	Compostos de imidazoquinolinas substituídas com sulfonamida e sulfamida e composição farmaceutica cotendo os mesmos
BR0206614A (pt)	2004-02-17	Composto, composição farmacêutica, método para inibir a polimerase viral de rna dependente de rna e/ou inibir a replicação viral de rna dependente de rna, método para tratar uma infecção viral de rna dependente de rna, e, uso de um composto
BR0107972A (pt)	2002-11-05	Uso de uma proteìna ou polinucleotìdeo tat do hiv, nef do hiv, ou tat do hiv ligado(a) a uma proteìna ou polinucleotìdeo nef do hiv (nef-tat), e de uma proteìna ou polinucleotìdeo gp120 do hiv, método para imunizar um ser humano contra o hiv, e, composição de vacina para o uso humano
BR0209658A (pt)	2004-04-20	Derivados de 4-amino-5-fenil-7-1ciclobutil-pirrolo [2,3-d] pirimidina
BR9811121A (pt)	2000-07-18	Produto, composição farmacêutica, e uso de um produto
NO20034204L (no)	2003-11-21	Farmasöytiske kombinasjoner til behandling av kreft
AR030068A1 (es)	2003-08-13	Composiciones farmaceuticas para el tratamiento de condiciones dolorosas, inflamatorias y ulcerosas de superficies epiteliales humedas como por ejemplo mucositis, estomatitis y sindrome de behcet
HRP20040059B1 (en)	2008-05-31	Treatment of nail infections with no
AR002255A1 (es)	1998-03-11	Una composicion que comprende una formulacion de antigeno microfluidizada y usos de dicha formulacion.
EE05065B1 (et)	2008-08-15	Karbamiidasendatud imidasokinoliinid, nende kasutamine raviks ja neid sisaldavad farmatseutilised preparaadid
BR0108435A (pt)	2004-06-15	Formulação e uso de entecavir de baixa dose
HUP0202502A2 (hu)	2002-11-28	Virális fertőzőképességet blokkoló peptidek és eljárások ezek alkalmazására
ES2188995T3 (es)	2003-07-01	Uso de un inhibidor de la h+, k+-atpasa en el tratamiento de los polipos nasales.
BR0317539A (pt)	2005-11-22	Métodos e composições para o tratamento de infecções por vìrus da herpes usando inibidores seletivos da ou ciclooxigenase-2 ou inibidores da ciclooxigenase-2 em combinação com agentes antivirais
PE61699A1 (es)	1999-07-08	Composicion farmaceutica de lamivudina
ES2041243T3 (es)	1993-11-16	Aplicacion de por lo menos un principio activo inhibidor o destructor de por lo menos un ser vivo unicelular o virus.
BR0206775A (pt)	2006-01-17	Uso de um medicamento para tratar um indivìduo infectado com hiv, por combinação de imunização com interrupção estruturada do tratamento anti-retrovirótico
ATE395064T1 (de)	2008-05-15	Kombinationspräparate von 3-n- formylhydroxylaminopropylphosphonsäurederivaten oder 3-n- acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
NO20055243L (no)	2005-11-08	Interferon beta ved alvorlig akutt respiratorisk syndrom (SARS)
ATE253938T1 (de)	2003-11-15	Pharmazeutische kombination von antiviralen wirkstoffen
BR9809127A (pt)	2000-08-01	Combinação, formulação farmacêutica, processo para o tratamento de uma infecção por hiv em um animal infectado, uso de (-) -(1s,4r)-4-[2-amino-6-(ciclopropil amino)-9h-purin-9-il)-2-ciclopenteno-1-metanol, e, pacote de paciente
CL2004001291A1 (es)	2005-05-06	Composicion farmaceutica que comprende compuestos carbociclicos y heterociclicos; y su uso para el tratamiento o profilaxis de la infeccion por influenza.
AR025340A1 (es)	2002-11-20	Composiciones farmaceuticas

Legal Events

Date	Code	Title	Description
2007-09-04	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 6O E 7O ANUIDADES.
2011-12-13	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1913 DE 04/09/2007.